<DOC>
	<DOCNO>NCT00726037</DOCNO>
	<brief_summary>This study design determine duration T reg suppression patient metastatic pancreatic cancer receive Ontak . The goal define optimal time future dendritic cell vaccine administration .</brief_summary>
	<brief_title>A Pilot Study , Evaluating Efficacy Regulatory T-cell Suppression Ontak Metastatic Pancreatic Cancer</brief_title>
	<detailed_description>Despite improve insight epidemiology biology , pancreatic cancer remain significant health problem evidence disappointing survival rate associate advanced disease . Because aggressive growth early metastatic dissemination , 20 % patient treat surgery time diagnosis . Furthermore , overall 5-year survival rate stage IV disease &lt; 5 % [ 1-3 ] despite chemotherapy . With dismal outlook , obvious novel treatment strategy require . There limited experience literature use Ontak treatment metastatic pancreatic cancer . Viehl , et al , demonstrate murine model pancreatic cancer , ontak combine whole tumor vaccine lead significantly increase T cell-dependent antitumor immune response , well improve survival compare control . Our group active trial Loyola evaluate role dendritic cell vaccine patient unresectable , metastatic , pancreatic cancer . Preliminary data suggest correlation time progression restoration Tregs follow initial decrease DC injection . The goal current proposal determine time point Tregs reach nadir within four week ontak injection . When determine , eventually propose administer ontak follow DC vaccine nadir Treg time point patient unresectable pancreatic cancer</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Denileukin diftitox</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>Male patient nonpregnant , nonlactating female patient &gt; 18 year old Histologic diagnosis pancreatic cancer distant disease see CT MRI prior chemotherapy radiotherapy least 4 week Karnofsky performance status equal great 70 % Life expectancy least 3 month . No uncontrolled pain No symptom bowel obstruction Women child bear potential must agree use adequate contraceptive . If become pregnant need inform treat physician Ability give inform consent Positive serologic test HIV , AIDS , human Tcell lymphotrophic virus type 1 , hepatitis B , hepatitis C. Hemoglobin &lt; 9g/dL ; hematocrit &lt; 27 % ; platelet &lt; 100,000/ U/L without transfusion support Creatinine &gt; 1.8 mg/dL Serum albumin &lt; 2.0 mg/dL AST &gt; 3X ULN ; ALT &gt; 3X ULN Bilirubin &gt; 1.8 Uncontrolled angina , arrhythmia , bronchospasm , hypertension , hypercalcemia . Corticosteroid use within 28 day Chemotherapy radiation within 28 day Bacteremia sign active systemic infection History autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Denileukin diftitox</keyword>
	<keyword>Metastatic Pancreatic Cancer</keyword>
	<keyword>Ontak</keyword>
	<keyword>Regulatory T-cell</keyword>
</DOC>